Sadhana Nitro Chem Ltd. - Quarterly/Annual Result Disclosures and Notes dated 30 Sep 2022

Notes on Standalone Financial Results:

1) The above unaudited standalone financial results for the quarter ended 30th September 2022 have been prepared in accordance with the applicable Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India in compliance with Regulation 33 of the Listing Regulations.

2) The above unaudited standalone financial results for the quarter ended 30th September 2022 have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 14th Novembe, 2022.

3) The limited review under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, has been carried out by the statutory auditors. Auditor's Review Report does not contain any observation which would have an impact on the above results.

4) The company is primarily engaged in one business segment ie. manufacturing of chemical intermediates, heavy organic chemicals and performance chemicals which is it's primary segment. The company is also engaged in the manufacture of wireless network equipment & services. However, since the revenue, profits & total assets of this segmentis less than 10% of the combined revenue, profits & assets of all the reporting segments, disclosures as required by Ind-As 108, ‘Operating Segments’ are not given.

5) During the quarter & half year ended 30th September, 2022, the company has received further application money in, July 2022 of additional 25% of issue price aggregating to Rs. 25,00,00,034/- towards the issue & allotment of 65,20,606 Share Warrants (on Preferential basis/ Issue), convertible into 65,20,606 equity shares of face value of Rs. 1/- each, at Rs. 153.36 (including premium of Rs. 152.36) per share Warrant / Equity Share approximately aggregating to Rs. 1,00,00,00,137/- pursuant to the approval of the board, shareholders and other applicable statutory provisions. On receipt of balance 50% of issue price aggregating to approximately 50,00,00,69/- within 12 months of date of allotment, each share warrant will be converted into one equity share.

6) Figures of the previous periods have been regrouped, wherever necessary.

7) Above financial result for the quarter ended 30th September, 2022 is available on www.bseindia.com and on the company’s website at www.sncl.com.